Histamine H3 antagonists as potential therapeutics in the CNS

Pharmacochemistry Library

Volumn 30, Issue C, 1998, Pages 255-267

  Onodera, Kenji ^a   Watanabe, Takehiko ^b  

^a TOHOKU UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957094364     PISSN: 01657208     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0165-7208(98)80034-2     Document Type: Article

References (56)

1. Schwartz J.C., Arrang J.M., Garbarg M., and Pollard H. In: Watanabe T., and Wada H. (Eds). Histaminergic Neurons: Morphology and Function (1991), CRC Press, Boca Raton 85
2. Arrang J.M., Garbarg M., and Schwartz J.C. Nature 302 (1983) 832
3. Arrang J.M., Garbarg M., and Schwartz J.C. Neuroscience 15 (1985) 553
4. Van Der Goot H., Schepers M.J.P., Sterk G.J., and Timmerman H. Eur. J. Med. Chem. 27 (1992) 511
5. Tedford C.E., Yates S.L., Paulowski G.P., Nalwalk J.W., Hough L.B., Khan M.A., Durant G.J., and Frederickson R.E.A. J. Pharmacol. Exp. Ther. 275 (1995) 598
6. Murakami K., Yokoyama H., Onodera K., Iinuma K., and Watanabe T. Meth. Find. Exp. Clin. Pharmacol. 17 Supl. C (1995) 70
7. Schunack W., Stark H., Purand K., Hüls A., Ligneau X., Arrang J.M., and Schwartz J.C. Abstract of XXVI European Histamine Research Society (Seville) (1998)
8. Schwartz J.C., Arrang J.M., Garbarg M., and Traiffort E. In: Bloom F.E., and Kupfer D.J.M. (Eds). Psychopharmacology; the fourth Generation of Progress (1995), Raven Press, New York 397
9. Wada H., Inagaki N., Yamatodani A., and Watanabe T. Trends Neurosci. 14 (1991) 415
10. Onodera K., Yamatodani A., Watanabe T., and Wada H. Prog. Neurobiol. 42 (1994) 685
11. Leurs R., and Timmerman H. Prog. Drug Res. 39 (1992) 127
12. De Almeida M.A.M.R., and Izquierdo I. Arch. Int. Pharmacodyn. Ther. 291 (1988) 202
13. Tasaka K. In: Tasaka K. (Ed). New Advances in Histamine Research (1994), Springer-Verlag, Tokyo 27
14. Miyazaki S., Imaizumi M., and Onodera K. Life Sci. 57 (1995) 1563
15. K. Meguro, K. Yanai, H. Yokoyama, A. Sakurai, K. Maeyama, T. Watanabe and T. Matsuzawa, 8 (1992) 299.
16. Miyazaki S., Imaizumi M., and Onodera K. Meth. Find. Exp. Clin. Pharmacol. 17 (1995) 653
17. Miyazaki S., Onodera K., Imaizumi K.M., and Timmerman H. Life Sci. 61 (1997) 355
18. Miyazaki S., Imaizumi M., and Onodera K. Life Sci. 57 (1995) 2137
19. Mochizuki T., Yamatodani A., Okakura K., Takemura M., Inagaki N., and Wada H. Naunyn-Schmied. Arch. Pharmacol. 343 (1991) 190
20. Yokoyama H., Onodera K., Maeyama K., Sakurai E., Iinuma K., Leurs R., Timmerman H., and Watanabe T. Eur. J. Pharmacol. 260 (1994) 23
21. Bhattachyrya S.K. Eur. J. Pharmacol. 183 (1990) 925
22. Schlicker E., Behling A., Lummen G., and Göthert M. Naunyn-Schmied. Arch. Pharmacol. 345 (1992) 489
23. Schlicker E., Fink K., Detzner M., and Göthert M. J. Neural Transm. 93 (1993) 1
24. Schlicker E., Betz R., and Göthert M. Naunyn-Schmied. Arch. Pharmacol. 337 (1988) 588
25. Clapham J., and Kilpatrick G.J. Br. J. Pharmacol. 107 (1992) 919
26. Philippu A. Annals of Psychiatry: Basic and Clinical Neuroscience 3 (1992) 79
27. Giacobini E. Prog. Brain Res. 98 (1993) 447
28. Karczmar A.G. Prog. Neuro-Psychopharmacol. Biol. Psychiat. 19 (1995) 187
29. Mochizuki T., Okakura-Mochizuki K., Horii A., Yamamoto Y., and Yamatodani A. J Neurochem. 62 (1994) 2275
30. Khateb A., Fort P., Pegna A., Jones B.E., and Mühlethaler M. Neuroscience 69 (1995) 495
31. Gorelova N., and Reiner P.B. J. Neurophysiol. 75 (1996) 707
32. Compton D.M., Dietrich K.M., Smith J.S., and Davis K. NeuroReport 7 (1995) 177
33. Imaizumi M., and Onodera K. Life Sci. 53 (1993) 1675
34. Oishi R., Nishibori M., Itoh Y., Shishido S., and Saeki K. Eur. J. Pharmacol. 184 (1990) 135
35. Tuomisto L., and Tacke U. Neuropharmacology 25 (1986) 955
36. Yokoyama H., Onodera K., Maeyama K., Yanai K., Iinuma K., Tuomisto L., and Watanabe T. Naunyn-Schmied. Arch. Pharmacol. 346 (1992) 40
37. Yokoyama H., Onodera K., Iinuma K., and Watanabe T. Psychopharmacology 112 (1993) 199
38. Yokoyama H., Onodera K., Iinuma K., and Watanabe T. Pharmacol. Biochem. Behav. 47 (1994) 503
39. Yokoyama H., Iinuma K., Yanai K., Watanabe T., Sakurai E., and Onodera K. Meth. Find. Exp. Clin. Pharmacol. 15 (1993) 183
40. Yokoyama H., Onodera K., Iinuma K., and Watanabe T. Eur. J. Pharmacol. 234 (1993) 129
41. Scherkl R., Hashem A., and Frey H.H. Epilepsy Res. 10 (1991) 111
42. Sakurai E., Gunji E., Iizuka Y., Hikichi N., Maeyama K., and Watanabe T. J. Pharmacol. Pharmac. 46 (1994) 209
43. Mochizuki T., Janssen F.P., Leurs R., Windhorst A.D., Yamatodani A., Maeyama K., and Timmerman H. Brain Res. 743 (1997) 178
44. Onodera K., and Ogura Y. In: Uvnäs B., and Tasaka K. (Eds). Advances in the Biosciences Vol. 33 (1982), Pergamon Press, Oxford 39
45. In: Uvnäs B., and Tasaka K. (Eds). Advances in the Biosciences 127 (1982), Pergamon Press, Oxford 39
46. Onodera K., and Watanabe T. Jpn. J. Psychopharmacol. 15 (1995) 87
47. Roll T.W., and Schleifer L.S. In: Gilman A.F., Goodman L.S., and Gilman A. (Eds). The Pharmacological Basis of Therapeutics. 6th Ed. (1975), Macmillan, New York 448
48. Lin J.S., Sakai K., and Jouvet M. Neuropharmacology 27 (1988) 111
49. Lin J.S., Sakai K., Vanni-Mercier G., Arrang J.M., Garbarg M., Schwartz J.C., and Jouvet M. Brain Res. 523 (1990) 325
50. Kathman M., Schliker E., and Göthert M. Psychopharmacology 116 (1994) 464
51. Rodrigues A.A., Jansen F.P., Leurs R., Timmerman H., and Prell G.D. Br J Pharmacol 114 (1995) 1523
52. Ryu J.H., Yanai K., and Watanabe T. Neurosci. Lett. 178 (1994) 19
53. Ryu J.H., Yanai K., Iwata R., Ido T., and Watanabe T. NeuroReport. 5 (1994) 621
54. Ryu J.H., Yanai K., Zhao X.L., and Watanabe T. Br J Pharmacol 118 (1996) 585
55. Sakata T. In: Watanabe T., and Wada H. (Eds). Histaminergic Neurons: Morphology and Function (1991), CRC Press, Boca Raton 297
56. Suzuki T., Takamori K., Takahashi Y., Narita M., Misawa M., and Onodera K. Life Sci. 54 (1994) 203